Quest Diagnostics said this week that Simplexa-branded tests for Epstein-Barr virus and BK virus from Quest's Focus Diagnostics business have been CE marked for distribution to more than 30 European countries.

The test kits, which uses real-time PCR and run on the 3M Integrated Cycler, are intended to aid in the clinical management of immunocompromised patients, Quest said. The cycler is a compact, portable testing platform that can provide results in as little as an hour following sample extraction.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.